ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,040,446 | -14.3% | 155,059 | +3.4% | 0.14% | +94.4% |
| Q2 2022 | $1,214,000 | -41.7% | 150,000 | 0.0% | 0.07% | +4.4% |
| Q1 2022 | $2,082,000 | -76.1% | 150,000 | -41.4% | 0.07% | -74.3% |
| Q3 2021 | $8,699,000 | -29.7% | 255,916 | -15.5% | 0.26% | -31.2% |
| Q2 2021 | $12,382,000 | +19.8% | 303,032 | +18.1% | 0.38% | +30.5% |
| Q1 2021 | $10,335,000 | -41.7% | 256,694 | -14.4% | 0.30% | -54.3% |
| Q4 2020 | $17,733,000 | +63.2% | 299,898 | +34.2% | 0.64% | +15.2% |
| Q3 2020 | $10,864,000 | +236.7% | 223,400 | +234.9% | 0.56% | +80.6% |
| Q2 2020 | $3,227,000 | -40.4% | 66,700 | -65.8% | 0.31% | -51.8% |
| Q1 2020 | $5,417,000 | +235.2% | 195,000 | +261.0% | 0.64% | +352.8% |
| Q4 2019 | $1,616,000 | -4.4% | 54,010 | +54.3% | 0.14% | -44.7% |
| Q2 2019 | $1,691,000 | – | 35,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |